Skip to main content
. 2013 Dec 24;6(1):54–65. doi: 10.3390/toxins6010054

Figure 1.

Figure 1

Effect of penta-O-galloyl-β-d-glucose (PGG) on erythrocyte forward scatter (A) Original histogram of forward scatter of erythrocytes following exposure for 48 h to Ringer solution without (grey) and with (black) the presence of 25 µM penta-O-galloyl-β-d-glucose; (B) Arithmetic means ± SEM (n = 8) of the normalized erythrocyte forward scatter (FSC) following incubation for 48 h to Ringer solution without (white bar) or with (black bars) penta-O-galloyl-β-d-glucose (1–50 µM). * (p < 0.05), *** (p < 0.001) indicates significant difference from the absence of penta-O-galloyl-β-d-glucose (ANOVA).